Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.
Start price
11.11.24
/
50%
€22.00
Target price
11.11.25
€33.80
Performance (%)
-10.57%
End price
12.11.25
€19.68
Summary
This prediction ended on 12.11.25 with a price of €19.68. The prediction for Catalyst Pharmaceutical Partners Inc disappointed with a performance of -10.57%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | - | - | - |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $30.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.68
09.08.24
09.08.24
€27.48
09.08.25
09.08.25
1.02%
10.08.25
10.08.25
